These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12008539)

  • 21. Anticholinergic effects in older adults. Weighing the risk-benefit ratio.
    Pollock BG
    Director; 2004; 12(4):230, 233. PubMed ID: 15540835
    [No Abstract]   [Full Text] [Related]  

  • 22. The pharmacokinetics of cefixime in patients with renal insufficiency undergoing hemofiltration.
    König S; Marre R; Schulz E; Sack K
    J Chemother; 1989 Jul; 1(4 Suppl):536-7. PubMed ID: 16312520
    [No Abstract]   [Full Text] [Related]  

  • 23. Gadolinium encephalopathy in a patient with renal failure.
    Maramattom BV; Manno EM; Wijdicks EF; Lindell EP
    Neurology; 2005 Apr; 64(7):1276-8. PubMed ID: 15824364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dose adjustment of ciprofloxacin in renal failure: reduce the dose or prolong the administration interval?
    Czock D; Rasche FM
    Eur J Med Res; 2005 Apr; 10(4):145-8. PubMed ID: 15946909
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Role of renal failure in the pathogenesis of adverse drug reactions in the elderly].
    Corsonello A; Pedone C; Corica F; Mazzei B; Mussi C; Di Iorio A; Incalzi RA
    Recenti Prog Med; 2006 Feb; 97(2):90-3. PubMed ID: 16671275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Preventing iatrogenic drug induced diseases in the elderly].
    Kiledjian E; Baumgartner-Bonnevay C; Derharoutunian C; Garreau I
    Soins Gerontol; 2003; (40):19-23. PubMed ID: 12696324
    [No Abstract]   [Full Text] [Related]  

  • 27. The effects of liver and renal dysfunction on the pharmacokinetics of sedatives and analgesics in the critically ill patient.
    Yogaratnam D; Miller MA; Smith BS
    Crit Care Nurs Clin North Am; 2005 Sep; 17(3):245-50. PubMed ID: 16115532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protecting patients from harm: reduce the risks of high-alert drugs.
    Cohen H
    Nursing; 2007 Sep; 37(9):49-55; quiz 1 p following 55. PubMed ID: 17728654
    [No Abstract]   [Full Text] [Related]  

  • 29. [Cytochromes P450, drug disease and personified medicine. Part 2. Therapeutic drug monitoring as a method of monooxygenase activity assessment].
    Archakov AI; Lisitsa AV; Petushkova NA; Karuzina II
    Klin Med (Mosk); 2008; 86(3):4-6. PubMed ID: 18441695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of angiotensin converting enzyme inhibitor on renal function in patients of membranoproliferative glomerulonephritis with mild to moderate renal insufficiency.
    Giri S; Mahajan SK; Sen R; Sharma A
    J Assoc Physicians India; 2002 Oct; 50():1245-9. PubMed ID: 12568207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ethics related to drug therapy in the elderly.
    Beglinger C
    Dig Dis; 2008; 26(1):28-31. PubMed ID: 18600011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Use of drugs in renal insufficiency. Contraindicated drugs (absolute and relative contraindication)].
    García Criado E; Aljama P
    Nefrologia; 2001; 21 Suppl 5():54-7. PubMed ID: 11881416
    [No Abstract]   [Full Text] [Related]  

  • 33. [New usage for an old drug: acetylcysteine for contrast-induced nephropathy].
    Asher I; Hammerman A; Sthoeger Z
    Harefuah; 2005 Sep; 144(9):642-6; 675. PubMed ID: 16218537
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The kidney and drugs. Disorders of the metabolism and kinetics of drugs in renal insufficiency].
    Devulder B; Plouvier B; Lemaire P
    Lille Med; 1976 Oct; 21(8):679-82. PubMed ID: 1004119
    [No Abstract]   [Full Text] [Related]  

  • 35. [Drugs and the nurse's role].
    Rev Infirm; 1999 Dec; (55):23-4. PubMed ID: 10776318
    [No Abstract]   [Full Text] [Related]  

  • 36. [Hazardous drugs in renal insufficiency].
    Andre P
    Soins; 1980 Feb; 25(4):25-9. PubMed ID: 6899436
    [No Abstract]   [Full Text] [Related]  

  • 37. Spironolactone-induced renal insufficiency and hyperkalemia in patients with heart failure.
    Tamirisa KP; Aaronson KD; Koelling TM
    Am Heart J; 2004 Dec; 148(6):971-8. PubMed ID: 15632880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vasoactive medication dosage and daily weight changes.
    Cooper B
    Crit Care Nurse; 2008 Apr; 28(2):136-7. PubMed ID: 18378733
    [No Abstract]   [Full Text] [Related]  

  • 39. Contrast media nephropathy: in depth review.
    Hussain N; Al Otaibi T; Nampoory MR
    Saudi J Kidney Dis Transpl; 2008 Mar; 19(2):174-82. PubMed ID: 18310863
    [No Abstract]   [Full Text] [Related]  

  • 40. Preventing contrast nephropathy: what is the best strategy? A review of the literature.
    Cox CD; Tsikouris JP
    J Clin Pharmacol; 2004 Apr; 44(4):327-37. PubMed ID: 15051739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.